Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249199 (US9457039, 22) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 930 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure inhibition of the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase by the nucleoside triphosphate compounds of the present ... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249201 (US9457039, 24) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure inhibition of the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase by the nucleoside triphosphate compounds of the present ... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249200 (US9457039, 23) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 6.70E+3 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure inhibition of the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase by the nucleoside triphosphate compounds of the present ... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249202 (US9457039, 25) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | 5.10E+4 | n/a | n/a | n/a | n/a | 7.3 | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure inhibition of the enzymatic activity of the HCV NS5B RNA-dependent RNA polymerase by the nucleoside triphosphate compounds of the present ... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249195 (US9457039, 20 | US9457039, 21) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249192 (US9457039, 16 | US9457039, 17) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249193 (US9457039, 18 | US9457039, 19) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249184 (US9457039, 7) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249186 (US9457039, 9) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249179 (US9457039, 2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249185 (US9457039, 8) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249190 (US9457039, 14 | US9457039, 15) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.80E+4 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249195 (US9457039, 20 | US9457039, 21) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249187 (US9457039, 10) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249188 (US9457039, 11) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249193 (US9457039, 18 | US9457039, 19) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249181 (US9457039, 4) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249182 (US9457039, 5) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249189 (US9457039, 12 | US9457039, 13) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249192 (US9457039, 16 | US9457039, 17) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249190 (US9457039, 14 | US9457039, 15) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249189 (US9457039, 12 | US9457039, 13) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249180 (US9457039, 3) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249183 (US9457039, 6) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair |